|
|
|
|
MATHYS MATTERS November 2025 |
|
Welcome to Mathys Matters - your monthly update from Mathys & Squire, covering all the recent intellectual property and sector news/updates throughout November!
This month we are shining a spotlight on the recent developments in gene therapy and the importance of patent protection in lifesaving innovation.
Our latest news and articles throughout November include: ''Treating ‘Untreatable’ Diseases: Gene Therapy and the Patent Battlefield", "Continuing trend of cutting-edge medical technology being used in the cosmetics industry", "Health trends and Gen Z drive 19% surge in UK non-alcoholic cocktail brands", "Mathys & Squire Partners featured in IAM Strategy 300 Global Leaders 2026", "Mathys & Squire sponsor ELRIG’s Forum for Drug Discovery" and more.
Scroll down to read more! |
|
|
|
We value your feedback and would appreciate your input to help us improve.
Please click on the image below. |
|
|
|
|
|
|
SPOTLIGHT OF THE MONTH
- Treating ‘Untreatable’ Diseases: Gene Therapy and the Patent Battlefield - |
|
|
Recent breakthroughs in the field of gene therapy are bringing us closer to curing and treating diseases which were previously unmanageable. |
|
With an increasingly intricate patent landscape, innovators must remain vigilant when navigating IP protection to ensure treatments can leave the lab. |
|
In this article, Associate Rogen Leung explores the latest developments in gene therapy within the context of a decade-long patent dispute, revealing the key strategies to protecting innovation in molecular medicine.
Click here to read more |
|
|
|
|
|
|
Continuing trend of cutting-edge medical technology being used in the cosmetics industry 21 November
Partner Samantha Moodie and Associate Clare Pratt have been featured in Life Sciences IP Review and Aesthetic Medicine providing commentary on the increased use of biotherapeutic molecules in the cosmetics industry.
Read the article here |
| Mathys & Squire Partners featured in IAM Strategy 300 Global Leaders 2026 24 November
We are proud to share that Mathys & Squire has been featured in IAM Strategy 300 Global Leaders 2026. Partners Anna Gregson, Dani Kramer and Martin MacLean have all been ranked in the 2026 edition, recognising their strategic expertise in IP and consistently exceptional work for clients.
Read the article here |
| IP Inclusive: Professionalism and Identity in the Workplace 4 November
In response to Black History Month, IPSS Electra Valentine has co-written an article on the importance of accepting and encouraging individualism within a professional environment, and how it should be separated from Eurocentric standards.
Read the article here |
|
| Health trends and Gen Z drive 19% surge in UK non-alcoholic cocktail brands 4 November
Partner Claire Breheny has been featured in FoodBev Media, MCA Insight and The Morning Advertiser, commenting on the wave of non-alcoholic drinks impacting the beverage market, and how brands are looking to meet this new demand.
Read the article here |
| Mathys & Squire sponsor ELRIG’s Forum for Drug Discovery 10 November
Earlier this month, Mathys & Squire was a Forum Partner for ELRIG's UK Forum on drug discovery at the University of Warwick, with Partner Martin MacLean and Managing Associate Lionel Newton attending the event. ELRIG is a not-for-profit organisation which fosters collaboration across the life sciences.
Read the article here |
| Author and former employee Ruth Leigh speaks at the Shard 13 November
For our November book club, former employee Ruth Leigh came into our London office to give a talk on her career journey and profession as an author. Ruth previously worked at Mathys & Squire as one of our support staff and became a writer in 2022.
Read the article here |
|
|
|
|
|
NEW PODCAST EPISODE
- Research to Reward: How to Commercialise Science - |
|
|
Universities play a vital role in the development of innovation through spin outs. However, there can often be challenges when bridging the gap between academia and industry. |
|
In this latest episode, Jim Shaikh uses his own professional experiences and expertise to highlight the best methods to protect your technology and grow, covering crucial aspects such as the purpose of Tech Transfer Offices (TTOs), the opportunities in licencing, and the importance of a strong IP strategy.
Click here to watch the full episode on YouTube or Spotify. |
|
|
|
|
|
|
|
Mathys & Squire T: +44 (0)20 7830 0000 E: info@mathys-squire.com
@Mathys_Squire www.mathys-squire.com
If you no longer wish to receive emails from us, click here to unsubscribe. |
|
